reference/5208928

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/5208928

Outgoing Links

Predicate	Object
contentType	Journal Article\|Multicenter Study
endingPage	1555
issn	0923-7534
issueIdentifier	6
pageRange	1549-1555
publicationName	Annals of oncology : official journal of the European Society for Medical Oncology
startingPage	1549
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_22eea0c588aa956d15373bef9ee7922c
bibliographicCitation	Heng DY, MacKenzie MJ, Vaishampayan UN, Bjarnason GA, Knox JJ, Tan MH, Wood L, Wang Y, Kollmannsberger C, North S, Donskov F, Rini BI, Choueiri TK. Primary anti-vascular endothelial growth factor (VEGF)-refractory metastatic renal cell carcinoma: clinical characteristics, risk factors, and subsequent therapy. Annals of Oncology. 2012 Jun;23(6):1549–55. doi: 10.1093/annonc/mdr533.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b6ec5b24aef1cb5cb6a2b0c862a829f1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e8562f5776b5c671aa6726535eeac878 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3f069ccd4c20259a62b755105973c751 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4687b460f408b49db39aff02171766a8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_40d4434145d65ee446f75dec76f06503 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_123fe60f58719692b5c0f6b90d3e21f6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_205d1953b44cbcfe9bc9784945b71d14 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eaf9a6b8ef5cf5dd8d7d7eaaa99a912f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0d22e111585b1eb334fa9475497b59d2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1ad0fa8ceccd1891520cdb3f44d93c13 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5406dc5c444bb4c42fb03aa08e5b3231 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2d44cb51b83eed53272a13b1434d71c7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d4b2bc22de65f97e530fd2040402eb02
date	201206
identifier	https://doi.org/10.1093/annonc/mdr533 https://pubmed.ncbi.nlm.nih.gov/22056973 https://pubmed.ncbi.nlm.nih.gov/PMC3858023
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1846 https://portal.issn.org/resource/ISSN/0923-7534
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Primary anti-vascular endothelial growth factor (VEGF)-refractory metastatic renal cell carcinoma: clinical characteristics, risk factors, and subsequent therapy
discusses	http://id.nlm.nih.gov/mesh/M0014833 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0328153 http://id.nlm.nih.gov/mesh/M0029863 http://id.nlm.nih.gov/mesh/M0556300 http://id.nlm.nih.gov/mesh/M0018233 http://id.nlm.nih.gov/mesh/M0011238 http://id.nlm.nih.gov/mesh/M0018276 http://id.nlm.nih.gov/mesh/M0443627 http://id.nlm.nih.gov/mesh/M0002336 http://id.nlm.nih.gov/mesh/M0016578 http://id.nlm.nih.gov/mesh/M000602394 http://id.nlm.nih.gov/mesh/M0498543 http://id.nlm.nih.gov/mesh/M0446095 http://id.nlm.nih.gov/mesh/M0448793
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D019008 http://id.nlm.nih.gov/mesh/D002292Q000188 http://id.nlm.nih.gov/mesh/D007680Q000188 http://id.nlm.nih.gov/mesh/D000970Q000494 http://id.nlm.nih.gov/mesh/D020533Q000494
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D061067Q000627 http://id.nlm.nih.gov/mesh/D011758Q000627 http://id.nlm.nih.gov/mesh/D016015 http://id.nlm.nih.gov/mesh/D011725Q000627 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D015999 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D001557Q000627 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D018572 http://id.nlm.nih.gov/mesh/D012307 http://id.nlm.nih.gov/mesh/D007211Q000627 http://id.nlm.nih.gov/mesh/D007211Q000494 http://id.nlm.nih.gov/mesh/D000068338 http://id.nlm.nih.gov/mesh/D000068258 http://id.nlm.nih.gov/mesh/D001557Q000494 http://id.nlm.nih.gov/mesh/D010671 http://id.nlm.nih.gov/mesh/D002292Q000401 http://id.nlm.nih.gov/mesh/D000077157 http://id.nlm.nih.gov/mesh/D009536Q000031 http://id.nlm.nih.gov/mesh/D020123Q000627 http://id.nlm.nih.gov/mesh/D020123Q000494 http://id.nlm.nih.gov/mesh/D020123Q000031 http://id.nlm.nih.gov/mesh/D011725Q000494 http://id.nlm.nih.gov/mesh/D053208 http://id.nlm.nih.gov/mesh/D007680Q000401 http://id.nlm.nih.gov/mesh/D061067Q000494 http://id.nlm.nih.gov/mesh/D000970Q000627 http://id.nlm.nih.gov/mesh/D000077210 http://id.nlm.nih.gov/mesh/D020533Q000627 http://id.nlm.nih.gov/mesh/D011758Q000494 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008875
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284616 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216239 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5329102 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6873 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_714b3f52d8149c3277181d9513b93112 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9409 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d0bb789479d34dbc0811f92fc2bc5049

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247499656 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID244328266 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID242749350 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248184126 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128611606 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248766214

Total number of triples: 99.